Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL.
Husby S, Bæch-Laursen C, Eskelund CW, Favero F, Jespersen JS, Hutchings M, Pedersen LB, Niemann CU, Weischenfeldt J, Räty R, Larsen TS, Kolstad A, Jerkeman M, Grønbæk K.
Husby S, et al. Among authors: jerkeman m.
Leukemia. 2022 Dec;36(12):2912-2916. doi: 10.1038/s41375-022-01725-8. Epub 2022 Oct 23.
Leukemia. 2022.
PMID: 36274067
No abstract available.